Narcolepsy

Authors

  • Fernando Morgadinho Santos Coelho Hospital Israelita Albert Einstein; Setor de Urgências
  • Rosilene Motta Elias Universidade de São Paulo; Hospital da Clínicas; Serviço de Hemodiálise
  • Márcia Pradella-Hallinan Instituto do Sono
  • Lia Rita Azeredo Bittencourt Unifesp; EPM; Departamento de Psicobiologia
  • Sérgio Tufik Universidade Federal de São Paulo; Escola Paulista de Medicina

DOI:

https://doi.org/10.1590/S0101-60832007000300005

Keywords:

Narcolepsy, genetics, immunology, diagnosis and treatment

Abstract

BACKGROUND: Narcolepsy is a chronic neurological syndrome with prevalence between 0.018% and 0.040% without important ethnic differences. Narcolepsy is characterized by excessive daytime sleepiness and cataplexy. The pathophysiology of the illness is not known; even so it possesses genetic marker (allele HLA DQB1 *0602) and with abnormalities in the neurotransmission of hypocretin has been described in patients with narcolepsy. OBJECTIVES: Resume news discoveries in narcolepsy and show diagnoses and treatment options. METHODS: Bibliographic review. RESULTS AND DISCUSSION: The diagnoses of narcolepsy must be done with The International Classification of Sleep Disorders criteria. The hypocretin dosage is the best exam to confirm diagnose in narcoleptic patients with typical cataplexy. The treatment is carried through with behavior actions and symptomatic drugs that promote the vigil and control the cataplexy. Differential diagnoses as schizophrenia, epilepsy, depression and others sleep disorders need to be eliminated.

Downloads

Download data is not yet available.

Published

2007-01-01

Issue

Section

Reviews of Literature

How to Cite